Overall Technical outlook

Price Summary

On 2026-02-27, Aurobindo Pharma Limited's stock began at 1225.3, peaked at 1240.0, declined to 1214.3, and ended the day -0.4% down at 1220.4, with 1780680 shares traded.
The stock's peak price over the last 52 weeks is 1257.8, with the lowest being 1022.2.
According to 27 analysts, the price of AUROPHARMA in the future is projected to be between 1020.0 and 1640.0, with an average expected price of 1345.1852.

Technicals

Support and Resistance: The current price for AUROPHARMA is 1220.4, supported at 1194.0 with resistance at 1239.3. This indicates a trading range where 1194.0 might prevent further declines, while 1239.3 could hinder additional gains.
AUROPHARMA supportResistance ef887f
Support/Resistance for AUROPHARMA


Aroon: The AROON is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
AUROPHARMA aroon ef887f
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AUROPHARMA bbands ef887f
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.
AUROPHARMA psar ef887f
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The stochastic indicator shows a bullish sentiment, with the K-line above both the D-line and the 80 level. This configuration indicates strong upward momentum, suggesting that AUROPHARMA may continue its upward trend. Traders might view this as a sign of sustained strength.
AUROPHARMA stoch ef887f
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
AUROPHARMA trippleSMA ef887f
Tripple SMA chart for Aurobindo Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.